Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Cytokine release syndrome (CRS) is a life-threatening complication of several new immunotherapies used to treat cancers and autoimmune diseases(1–5). Here we report that atrial natriuretic peptide can protect mice from CRS induced by such agents by reducing the levels of circulating catecholamines....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nature
Asıl Yazarlar: Staedtke, Verena, Bai, Ren-Yuan, Kim, Kibem, Darvas, Martin, Davila, Marco L., Riggins, Gregory J., Rothman, Paul B., Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Zhou, Shibin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512810/
https://ncbi.nlm.nih.gov/pubmed/30542164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41586-018-0774-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller